Le Lézard
Classified in: Health
Subjects: TRI, FVT

$3M Awarded for Binge Eating Research Study in Colorado


DENVER, Feb. 27, 2018 /PRNewswire/ -- After receiving a $3M grant through the National Institute of Mental Health (NIMH) in December 2017, EDCare Denver and University of Colorado Denver's Brain Research Program will begin collaborating on a five-year research study on binge eating.

Started by Dr. Guido Frank titled, "Effects of Negative Affect in Individuals with Binge Eating Episodes," the study is underway and currently seeking participants with the goal to better understand how brain function drives binge eating. Binge eating is characterized by recurrent episodes of eating large amounts of foods, eating much more rapidly than normal and until feeling uncomfortably full, as well as feeling disgusted with oneself, depressed, or guilty after those episodes. Behavior studies have shown that negative affect and negative urgency (the tendency to act rashly when distressed) often drive binge eating.

Major health concerns relating to binge eating disorders include reduced quality of life and increased mortality rate, and the available treatments are limited. The neurobiology underlying binge eating is not well understood and has not specifically been studied in a trans-diagnostic approach using the NIMH's research domain criteria.

Study participants will include 200 men and women with bulimia nervosa, binge eating disorder, obesity, as well as healthy comparison individuals, ages 18 to 55 years old. Dr. Frank's research team comprised of Tamara Pryor, PhD, FAED; Megan Shott, BS; Marisa Deguzman, B.A., B.S.; and Brogan Rossi, BS, will aim to bridge the knowledge gap that exists for the following factors of binge eating:

"We are so thankful for the funding from the National Institute of Mental Health to support this project and to be partnering with EDCare," said Dr. Frank, Associate Professor of Psychiatry and Neuroscience, University of Colorado Anschutz Medical Campus; Associate Medical Director, Eating Disorders Program, Children's Hospital Colorado; and Director, Developmental Brain Research Program. "We are still in the beginning stages of our study and are actively recruiting participants. Our end goal is to use this study's results to improve treatment for people suffering from binge eating disorders. We hope to make treatment easier, shorter and more successful."

EDCare's treatment strategies for BED patients include psychological treatment (Cognitive Behavioral Therapy and Acceptance and Commitment Therapy); normalizing intake; and medication as indicated. After conducting a study in 2013, EDCare has already found positive outcomes from Cognitive Behavioral Therapy (CBT) based treatment for Binge Eating Disorder in a partial hospitalization program. The results suggested that CBT and specific nutritional therapy, combined with traditional eating disorder programming, effectively addressed both the underlying psychological problems, reduced or eliminated bingeing behaviors, and effectively treated the physiologic co-morbidities.

"EDCare prides itself by developing opportunities for patients to participate in cutting edge research studies that result in new clinical interventions," said Dr. Tamara Pryor, Executive Clinical Director and Director of Clinical Research at EDCare. "The passion and dedication of Dr. Frank and the members of the Brain Research Program to increasing the understanding of the neurobiology of eating disorders is already well known. It is an honor to be able to work alongside their team."

To learn more, visit https://eatingdisorder.care/research/.

CONTACT: Amanda Ford, 970.449.6870

 

SOURCE EDCare


These press releases may also interest you

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....

at 17:58
More than 200 workers at American Medical Response (AMR) in Springfield and Greenfield have voted overwhelmingly to join Teamsters Local 404....

at 17:54
The American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, is celebrating National Doctors Day by highlighting three top kidney medical experts and authors known for their...

at 17:20
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on March 28, 2024. One individual was...

at 17:15
Paladin Labs Inc., a subsidiary of Endo International plc , today announced Health Canada's approval of WAKIX® (pitolisant hydrochloride tablets) for the treatment of excessive daytime sleepiness (EDS) or cataplexy in pediatric patients aged 6 years...

at 17:05
Sirona Biochem Corp. ("Sirona") announces the voting results from its Annual General Meeting of Shareholders (the "Meeting"), held in Vancouver, British Columbia on March 28, 2024. The total number of shares represented by shareholders present in...



News published on and distributed by: